Dong-A University Hospital

• Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism

  Collaborator, Phase 4, Not yet recruiting, 2,300 people, 1 Oct 2026

• NCT05909826

  Phase 2, Not yet recruiting, 49 people, 18 Jun 2023

• NCT03778593

  Phase 2, Completed, 34 people, 19 Dec 2018

• NCT02056847

  Collaborator, Phase 4, Completed, 313 people, 6 Feb 2014

• NCT01138904

  Phase 2, Completed, 80 people, 8 Jun 2010

• NCT01127555

  Collaborator, Phase 2, Completed, 30 people, 21 May 2010

• NCT01068392

  Phase 2, Completed, 42 people, 12 Feb 2010

• NCT00922896

  Collaborator, Phase 2, Completed, 22 people, 17 Jun 2009

Sources: clinicaltrials.gov